Cargando…

Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1

BACKGROUND: Malignant peripheral nerve sheath tumors (MPNSTs) are a serious complications of neurofibromatosis type 1 associated with poor prognosis and deeper lesions can be difficult to diagnose. 18-FDG PET improves the detection of malignancies. However, the criteria for malignancy, notably the S...

Descripción completa

Detalles Bibliográficos
Autores principales: Combemale, Patrick, Valeyrie-Allanore, Laurence, Giammarile, Francesco, Pinson, Stephane, Guillot, Bernard, Goulart, Denis Mariano, Wolkenstein, Pierre, Blay, Jean Yves, Mognetti, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916322/
https://www.ncbi.nlm.nih.gov/pubmed/24516522
http://dx.doi.org/10.1371/journal.pone.0085954
_version_ 1782302693314789376
author Combemale, Patrick
Valeyrie-Allanore, Laurence
Giammarile, Francesco
Pinson, Stephane
Guillot, Bernard
Goulart, Denis Mariano
Wolkenstein, Pierre
Blay, Jean Yves
Mognetti, Thomas
author_facet Combemale, Patrick
Valeyrie-Allanore, Laurence
Giammarile, Francesco
Pinson, Stephane
Guillot, Bernard
Goulart, Denis Mariano
Wolkenstein, Pierre
Blay, Jean Yves
Mognetti, Thomas
author_sort Combemale, Patrick
collection PubMed
description BACKGROUND: Malignant peripheral nerve sheath tumors (MPNSTs) are a serious complications of neurofibromatosis type 1 associated with poor prognosis and deeper lesions can be difficult to diagnose. 18-FDG PET improves the detection of malignancies. However, the criteria for malignancy, notably the SUVmax threshold, are not standardized. Therefore, the aim of the study was to evaluate a semi-quantitative index for the reproducible detection of MPNST with FDG PET. METHODS: It is a multicenter retrospective study conducted between 2000 to 2012. All patients with NF1 referred for suspected MPNST underwent PET. Since SUVmax was not available until 2004 in our centers, we had to settle for the semi-quantitative method used at that time, the uptake ratio between the tumor and the normal liver (T/L ratio) with 1.5 as the cut-off for malignancy. When dedicated PET with SUVmax became available, the semi-quantitative analysis of PET images remained, along with SUVmax. RESULTS: 113 patients with 145 tumors were included. PET assessment revealed 65 suspected lesions with T/L >1.5 and among these, 40 were MPNSTs. 80 tumors were classified as non-suspicious, and 79 were benign. The 1.5 T/L cut-off had a negative predictive value (NPV) of 98,8% and a positive predictive value of 61,5%. The positive likelihood ratio (LR) was 4,059, the negative LR was 0,032 with 97% sensitivity and 76% specificity. CONCLUSIONS: This study, which is among the largest published, confirms the utility of PET for detecting NF1-associated MPNSTs. A semi-quantitative index, the T/L ratio with a cut-off of 1.5, allowed sensitive and specific differentiation of malignant from benign tumors better than SUVmax. When T/L was <1.5, MPNSTs were ruled out with 98,8% NPV. When T/L was >1.5, there was a strong suspicion of malignancy. This semi-quantitative analytical method is as simple as SUVmax, but is more sensitive, more reproducible and non-user-dependent.
format Online
Article
Text
id pubmed-3916322
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39163222014-02-10 Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1 Combemale, Patrick Valeyrie-Allanore, Laurence Giammarile, Francesco Pinson, Stephane Guillot, Bernard Goulart, Denis Mariano Wolkenstein, Pierre Blay, Jean Yves Mognetti, Thomas PLoS One Research Article BACKGROUND: Malignant peripheral nerve sheath tumors (MPNSTs) are a serious complications of neurofibromatosis type 1 associated with poor prognosis and deeper lesions can be difficult to diagnose. 18-FDG PET improves the detection of malignancies. However, the criteria for malignancy, notably the SUVmax threshold, are not standardized. Therefore, the aim of the study was to evaluate a semi-quantitative index for the reproducible detection of MPNST with FDG PET. METHODS: It is a multicenter retrospective study conducted between 2000 to 2012. All patients with NF1 referred for suspected MPNST underwent PET. Since SUVmax was not available until 2004 in our centers, we had to settle for the semi-quantitative method used at that time, the uptake ratio between the tumor and the normal liver (T/L ratio) with 1.5 as the cut-off for malignancy. When dedicated PET with SUVmax became available, the semi-quantitative analysis of PET images remained, along with SUVmax. RESULTS: 113 patients with 145 tumors were included. PET assessment revealed 65 suspected lesions with T/L >1.5 and among these, 40 were MPNSTs. 80 tumors were classified as non-suspicious, and 79 were benign. The 1.5 T/L cut-off had a negative predictive value (NPV) of 98,8% and a positive predictive value of 61,5%. The positive likelihood ratio (LR) was 4,059, the negative LR was 0,032 with 97% sensitivity and 76% specificity. CONCLUSIONS: This study, which is among the largest published, confirms the utility of PET for detecting NF1-associated MPNSTs. A semi-quantitative index, the T/L ratio with a cut-off of 1.5, allowed sensitive and specific differentiation of malignant from benign tumors better than SUVmax. When T/L was <1.5, MPNSTs were ruled out with 98,8% NPV. When T/L was >1.5, there was a strong suspicion of malignancy. This semi-quantitative analytical method is as simple as SUVmax, but is more sensitive, more reproducible and non-user-dependent. Public Library of Science 2014-02-06 /pmc/articles/PMC3916322/ /pubmed/24516522 http://dx.doi.org/10.1371/journal.pone.0085954 Text en © 2014 Combemale et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Combemale, Patrick
Valeyrie-Allanore, Laurence
Giammarile, Francesco
Pinson, Stephane
Guillot, Bernard
Goulart, Denis Mariano
Wolkenstein, Pierre
Blay, Jean Yves
Mognetti, Thomas
Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1
title Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1
title_full Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1
title_fullStr Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1
title_full_unstemmed Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1
title_short Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1
title_sort utility of 18f-fdg pet with a semi-quantitative index in the detection of sarcomatous transformation in patients with neurofibromatosis type 1
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916322/
https://www.ncbi.nlm.nih.gov/pubmed/24516522
http://dx.doi.org/10.1371/journal.pone.0085954
work_keys_str_mv AT combemalepatrick utilityof18ffdgpetwithasemiquantitativeindexinthedetectionofsarcomatoustransformationinpatientswithneurofibromatosistype1
AT valeyrieallanorelaurence utilityof18ffdgpetwithasemiquantitativeindexinthedetectionofsarcomatoustransformationinpatientswithneurofibromatosistype1
AT giammarilefrancesco utilityof18ffdgpetwithasemiquantitativeindexinthedetectionofsarcomatoustransformationinpatientswithneurofibromatosistype1
AT pinsonstephane utilityof18ffdgpetwithasemiquantitativeindexinthedetectionofsarcomatoustransformationinpatientswithneurofibromatosistype1
AT guillotbernard utilityof18ffdgpetwithasemiquantitativeindexinthedetectionofsarcomatoustransformationinpatientswithneurofibromatosistype1
AT goulartdenismariano utilityof18ffdgpetwithasemiquantitativeindexinthedetectionofsarcomatoustransformationinpatientswithneurofibromatosistype1
AT wolkensteinpierre utilityof18ffdgpetwithasemiquantitativeindexinthedetectionofsarcomatoustransformationinpatientswithneurofibromatosistype1
AT blayjeanyves utilityof18ffdgpetwithasemiquantitativeindexinthedetectionofsarcomatoustransformationinpatientswithneurofibromatosistype1
AT mognettithomas utilityof18ffdgpetwithasemiquantitativeindexinthedetectionofsarcomatoustransformationinpatientswithneurofibromatosistype1